An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.
GE Healthcare has already filed five global patents for its design.
Broader market outperformed with the S&P BSE Midcap index adding 0.7%, while S&P BSE Smallcap index gained 0.6%.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
Instant noodle from Nestle is not the first food brand in India to have faced a tough time though
The new test it will enable rapid testing amongst more people easily.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India
The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of the Indian diplomat whose arrest had triggered a row between the two countries.
With the threat of COVID-19 pandemic continuing to loom over the world, the Ministry of Ayush has come out with a comprehensive document putting forth the concept of 'holistic health'.
Indian companies have made acquisitions of $1 billion so far in January
In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".
The matter is now expected to be raised with the PMO.
In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.
Earning woes drag markets lower; TCS, HUL lead fall.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
TCS, Infosys and Wipro were down 0.4-2% each. Capital goods majors also ended lower with L&T and BHEL down 1.4-3.9% each.
The deadly virus, which has killed over 5,000 people globally, has spread to 46 of the 50 US states.
Investors will maintain a cautious stance.
Zuckerberg leads the pack with a net worth of $47.1 billion.
Markets ended their lowest close in 2015 on fears of FII outflows as the US Fed may hike rates.
Experts question Nestle's silence over Maggi controversy.
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
Money managers have turned cautious about the technology space.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
.jpg)
Markets ended flat on Tuesday, amid a volatile trading session, as investors exercised caution ahead of the two-day FOMC meet starting today and Reserve Bank of India's monetary policy later this week.
Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
US country head, key departmental heads leave; more likely to follow.
Trump attributed the spike in the confirmed cases of coronavirus to the large-scale testing of the deadly disease.
Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.
On BSE, 1,469 shares fell and 1,200 shares rose. A total of 190 shares were unchanged.
An overarching law governing public healthcare is a glaring gap in India's fight against the COVID-19 pandemic. In India it is left to individuals to quarantine themselves voluntarily. Moreover, the 123-year old The Epidemic Diseases Act, 1897, governs healthcare emergencies in India.
The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances